Kolexia
Santagostino Alberto Hématologie
Santagostino Alberto
Hématologie
Centre Hospitalier de Troyes
Troyes, France
67 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Leucémie aigüe myéloïde Leucémie myéloïde Myélome multiple Tumeurs à plasmocytes Purpura Purpura thrombopénique Lymphomes Purpura thrombopénique idiopathique

Collaborateurs

Voir plus
Gavril Daniela
Gavril Daniela
Centre Hospitalier de Troyes, Troyes, France
Misra Srimanta
Misra Srimanta
Hôpital Paul Brousse, Villejuif, France
Vergnolle Sébastien
Vergnolle Sébastien
Gcs Moyens Labo Pub Interhos-ch Troyes, Troyes, France
Ali Ammar-Melab Nadia
Ali Ammar-Melab Nadia
Centre Hospitalier de Troyes, Troyes, France

Industries

Voir plus
B3TSI
65 collaboration(s)
Dernière en 2023
A+A
53 collaboration(s)
Dernière en 2023
Janssen
24 collaboration(s)
Dernière en 2023
IQVIA
20 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
Hématologie : à Troyes, deux soignants, un service précieux
Libération   29 novembre 2023
Gemtuzumab Ozogamicin for Patients with Newly Diagnosed CD33 Positive Acute Myeloid Leukemia: Results from a French Retrospective Observational Study
65th ASH Annual Meeting Abstracts   02 novembre 2023
Multicenter Open Label Phase 3 Benefit Study of Isatuximab Plus Lenalidomide and Dexamethasone with/without Bortezomib in the Treatment of Newly Diagnosed Non-Frail Transplant Ineligible Multiple Myeloma Elderly Patients. IFM2020-05
65th ASH Annual Meeting Abstracts   02 novembre 2023
Acute Myeloid Leukemia Patients Who Stopped Venetoclax or/and Azacytidine for Other Reasons Than Progression Have a Prolonged Treatment Free Remission and Overall Survival. a Filo Study
65th ASH Annual Meeting Abstracts   02 novembre 2023
PCP: A Phase I/II, Multi-center, Open Label Study of Pomalidomide, Cyclophosphamide and Prednisone (PCP) in Patients With Multiple Myeloma Relapsed and/or Refractory to Lenalidomide
Essai Clinique (Fondazione EMN Italy Onlus)   28 juin 2023
Retrospective, real-life study of venetoclax plus azacitidine or low-dose cytarabine in French patients with acute myeloid leukemia ineligible for intensive chemotherapy.
Cancer medicine   08 décembre 2022
Étude observationnelle prospective sur les Patients attEints de Purpura Thrombopénique Idiopathique (PTI) traités par des agonisTEs des R-TPO (ARTPO) : Eltrombopag et Romiplostim (Étude PEPITE)
85e CONGRÈS FRANÇAIS DE MÉDECINE INTERNE   01 décembre 2022
Long-Term Survival of Acute Myeloid Leukemia Responding Patients Who Stopped Azacytidine and/or Venetoclax Because of Poor Tolerance or Physician Choice: A Retrospective Multicenter Study from the French Innovative Leukemia Organization (FILO)
Annual Meeting Abstracts 2022   15 novembre 2022
Gilteritinib Activity in Refractory or Relapsed FLT3-Mutated Acute Myeloid Leukemia Patients Previously Treated By Intensive Chemotherapy and Midostaurin: A Study from the French AML Intergroup ALFA/Filo
Annual Meeting Abstracts 2022   15 novembre 2022
Prospective Follow-up of Patients with Myelofibrosis (MF) and Treated with Ruxolitinib in France: The Rumycup Study
Annual Meeting Abstracts 2022   15 novembre 2022